A detailed history of Virtus Investment Advisers, Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 9,059 shares of CELC stock, worth $837,413. This represents 0.14% of its overall portfolio holdings.

Number of Shares
9,059
Previous 7,487 21.0%
Holding current value
$837,413
Previous $99,000 349.49%
% of portfolio
0.14%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$12.58 - $62.68 $19,775 - $98,532
1,572 Added 21.0%
9,059 $445,000
Q2 2025

Aug 13, 2025

SELL
$8.21 - $13.35 $45,425 - $73,865
-5,533 Reduced 42.5%
7,487 $99,000
Q1 2025

May 14, 2025

BUY
$8.62 - $13.62 $112,232 - $177,332
13,020 New
13,020 $131,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $1.38B
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Virtus Investment Advisers, Inc. Portfolio

Follow Virtus Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.